Literature DB >> 3718820

The role of radiotherapy after chemotherapy in the management of persistent para-aortic nodal disease in non-seminomatous germ cell tumours.

G Read, R J Johnson, P M Wilkinson.   

Abstract

In the years 1979-1982, 83 patients with malignant teratoma of the testis who had retroperitoneal adenopathy at presentation or after a period of surveillance were treated. Complete radiological resolution of disease was obtained in 34 patients and a residual mass remained in 26, the remainder having progression of the para-aortic or other metastatic disease. There was no para-aortic relapse in 47 patients receiving radiotherapy post-chemotherapy whereas 2/11 who did not receive radiotherapy or an immediate retroperitoneal node dissection relapsed. Morbidity from radiotherapy was minimal apart from subcutaneous fibrosis in the irradiated area of 6 patients. It is concluded that radiotherapy is effective in sterilising minimal residual tumour post-chemotherapy and may be considered as an alternative to surgery.

Entities:  

Mesh:

Year:  1986        PMID: 3718820      PMCID: PMC2001375          DOI: 10.1038/bjc.1986.105

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Testicular cancer and the legacy of chemotherapy.

Authors:  F M Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

2.  Prospective study of follow up alone in stage I teratoma of the testis.

Authors:  G Read; R J Johnson; P M Wilkinson; B Eddleston
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

3.  Complications of thoracoabdominal retroperitoneal lymph node dissection.

Authors:  D G Skinner; A Melamud; G Lieskovsky
Journal:  J Urol       Date:  1982-06       Impact factor: 7.450

4.  Complications of retroperitoneal lymph node dissection.

Authors:  J P Donohue; R G Rowland
Journal:  J Urol       Date:  1981-03       Impact factor: 7.450

5.  Treatment and surgical staging of testicular and primary extragonadal germ cell cancer.

Authors:  M B Garnick; G P Canellos; J P Richie
Journal:  JAMA       Date:  1983-10-07       Impact factor: 56.272

6.  Cytoreductive surgery for advanced nonseminomatous germ cell tumors of testis.

Authors:  J Brenner; D Vugrin; W F Whitmore
Journal:  Urology       Date:  1982-06       Impact factor: 2.649

7.  Evaluation of radiotherapy and/or surgicopathological staging after chemotherapy in the management of metastatic germ cell tumours.

Authors:  R T Oliver; J P Blandy; W F Hendry; J P Pryor; J P Williams; H F Hope-Stone
Journal:  Br J Urol       Date:  1983-12

8.  The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer.

Authors:  D Vugrin; W F Whitmore
Journal:  Cancer       Date:  1985-05-01       Impact factor: 6.860

9.  Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.

Authors:  D Tait; M J Peckham; W F Hendry; P Goldstraw
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

  9 in total
  1 in total

Review 1.  Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario.

Authors:  Giulio Francolini; Luca Eolo Trodella; Giulia Marvaso; Fabio Matrone; Luca Nicosia; Giorgia Timon; Lucia Ognibene; Annamaria Vinciguerra; Ciro Franzese; Paolo Borghetti; Stefano Arcangeli
Journal:  Int J Clin Oncol       Date:  2021-07-17       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.